Literature DB >> 10102616

Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification.

M D Hughson1, S Bigler, K Dickman, G Kovacs.   

Abstract

End-stage renal disease (ESRD) patients have an increased risk of carcinoma of the kidney, thought to result from development of a disproportionately high number of papillary renal cell carcinomas. This study was undertaken to discover whether these renal carcinomas have a deletion of the short arm of chromosome 3, which characterizes conventional (clear cell) carcinomas, or trisomies of chromosomes 7 and 17, which characterize the majority of sporadic papillary renal cell neoplasms. Archival specimens from 17 end-stage kidneys containing renal cell carcinomas were collected from 16 ESRD patients. DNA was extracted from paraffin blocks of tumor and nontumorous tissue. Microsatellites on the long and short arm of chromosomes 3, 7, and 17 were amplified in paired "normal" tumor samples. Heterozygous loci were analyzed for loss of heterozygosity, indicating a deletion, and for allele ratio differences, indicating a duplication. Successful microsatellite studies were obtained on 18 tumors (2 conventional carcinomas, 14 papillary carcinomas, 2 unclassified [solid, eosinophilic cell] carcinomas). Of the papillary carcinomas, none had a 3p deletion, five had trisomies of both chromosomes 7 and 17, six had no changes in chromosomes 7 and 17, and three had either trisomy 7 or trisomy 17 but not both. A 3p deletion was present in one of two conventional carcinomas. No chromosome 3, 7, or 17 changes were identified in the unclassified carcinomas. The genetic abnormalities in 6 of 18 ESRD tumors seemed to be the same as those found in sporadic papillary or conventional renal cell carcinomas. Nine of 14 papillary carcinomas did not show allelic duplications of chromosomes 7 and 17. This is uncharacteristic of the findings reported for most of the sporadic forms of the neoplasm and suggests that the genetic mechanism underlying the development of many papillary renal cell carcinomas in ESRD patients might be different than that of the general population.

Entities:  

Mesh:

Year:  1999        PMID: 10102616

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  7 in total

1.  Acquired cystic disease-associated renal cell carcinoma with gain of chromosomes 3, 7, and 16, gain of chromosome X, and loss of chromosome Y.

Authors:  Naoto Kuroda; Tomoyuki Shiotsu; Ondrej Hes; Michal Michal; Taro Shuin; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2011-01-26       Impact factor: 2.309

2.  Expression and amplification of Topoisomerase-2α in type 1 and type 2 papillary renal cell carcinomas and its correlation with HER2/neu amplification.

Authors:  Fusun Duzcan; Suleyman Ender Duzcan; Sait Sen; Kutsal Yorukoglu; Vildan Caner; Nilay Sen Turk; Gokhan Ozan Cetin; Canan Kelten; Burcin Tuna; Banu Sarsik; Emre Tepeli
Journal:  Pathol Oncol Res       Date:  2011-04-02       Impact factor: 3.201

3.  Comparison of prognosis between patients with renal cell carcinoma on hemodialysis and those with renal cell carcinoma in the general population.

Authors:  Yasunobu Hashimoto; Toshio Takagi; Tsunenori Kondo; Junpei Iizuka; Hirohito Kobayashi; Kenji Omae; Kazuhiko Yoshida; Kazunari Tanabe
Journal:  Int J Clin Oncol       Date:  2015-03-12       Impact factor: 3.402

4.  End-stage kidney disease: gains of chromosomes 7 and 17 and loss of Y chromosome in non-neoplastic tissue.

Authors:  Ondrej Hes; Radek Síma; Jana Nemcová; Milan Hora; Stela Bulimbasic; Dmitry V Kazakov; Tomás Urge; Tomás Reischig; Miroslav Dvorák; Michal Michal
Journal:  Virchows Arch       Date:  2008-09-16       Impact factor: 4.064

5.  Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinoma.

Authors:  Melinda E Sanders; Rosemarie Mick; John E Tomaszewski; Frederic G Barr
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

Review 6.  Renal cell carcinoma of native kidney in Chinese renal transplant recipients: a report of 12 cases and a review of the literature.

Authors:  Chi Yuen Cheung; Man Fai Lam; King Chung Lee; Gavin Sheung Wai Chan; Kwok Wah Chan; Ka Foon Chau; Chun Sang Li; Tak Mao Chan; Kar Neng Lai
Journal:  Int Urol Nephrol       Date:  2011-03-10       Impact factor: 2.370

Review 7.  Kidney pathology: current classification of renal cell carcinoma.

Authors:  Jonathan W Said; George Thomas; Amnon Zisman
Journal:  Curr Urol Rep       Date:  2002-02       Impact factor: 2.862

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.